HK Stock MarketDetailed Quotes

3D MEDICINES (01244)

Watchlist
  • 2.910
  • 0.0000.00%
15min DelayNoon Break Jun 15 09:00 CST
751.30MMarket Cap-3.82P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

3D MEDICINES (01244) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
生物制药研发及商业化356.09M100.00%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
生物制药研发及商业化356.09M100.00%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
The mainland of China356.09M100.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +0.66%
Sample Name
Sample Code
 0.00%
Sample Name
Sample Code
 -2.38%
4
CNOOC
00883
-5.30%
5
KUNLUN ENERGY
00135
-5.36%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.08%
Sample Name
Sample Code
 +0.45%
Sample Name
Sample Code
 -1.57%
4
Rockchip Electronics
603893
-7.52%
5
MeiG Smart Technology
002881
-8.40%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -